“…Despite this fact, there has not been commensurate attention to the HIV prevention needs of these young MSM (Mustanski, Garofalo, Herrick, & Donenberg, 2007). In fact, several recent reviews that identified[60 published articles on randomized controlled trials or quasi-experimental studies on HIV risk reduction interventions for adolescents (*age\18) failed to report even one effective intervention targeted at adolescent MSM, while effective interventions have been described for many other populations at lower risk (Johnson, Carey, Marsh, Levin, & Scott-Sheldon, 2003;Malow, Rosenberg, Donenberg, & Devieux, 2006;Mullen, Ramirez, Strouse, Hedges, & Sogolow, 2002;Pedlow & Carey, 2004;Robin et al, 2004;Semaan et al, 2002). With most prevention funders requiring existing evidence of program effectiveness, the absence of such research on adolescent MSM effectively eliminates major sources of programmatic funding for this high risk group and thereby limits the ability to address these health disparities.…”